LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $-3.8M | $-923.3K | $-655.9K | $-539.6K |
| Depreciation & Amortization | — | — | — | — |
| Depreciation | $1.2K | $1.2K | $1.2K | $1.2K |
| Amortization | — | — | — | — |
| Stock-Based Compensation | — | $46.2K | — | $53.8K |
| Net Cash from Operating Activities | $-2.1M | $-349.7K | $-508.6K | $-404.1K |
| Investing Activities | ||||
| Capital Expenditures | — | — | — | — |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | — | $125.0K | — | $200.0K |
| Net Change in Cash | — | — | — | — |
| Free Cash Flow | — | — | — | — |